Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00239642 · ClinicalTrials.gov registry record · Phase 4

Safety and Efficacy of Iron Sucrose in Children

A Phase 4 study, sponsored by American Regent.

Completed
Registry status
Phase 4
Development phase
141
Enrollment target

NCT00239642 is a Phase 4 study that has completed, run by American Regent. The registered enrollment target is 141 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00239642, a Phase 4 study, has completed, sponsored by American Regent.

COMPLETED
Registry status
Phase 4
Development phase
141 participants
Enrollment target

Study Summary

Comparison of three potential iron sucrose maintenance regimens in pediatric chronic kidney disease (CKD) patients

Interventions

  • DRUG Venofer (iron sucrose injection)

Trial Details

FieldValue
Enrollment Target 141 participants
Start Date 2005-07
Est. Completion 2010-04
Phase Phase 4

Sponsor

American Regent

34 total trials

What the Registry Record Tells You About NCT00239642

The ClinicalTrials.gov registry entry for NCT00239642 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American Regent, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Venofer (iron sucrose injection) is the first listed.

NCT00239642 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00239642 about?

NCT00239642 is a clinical study titled "Safety and Efficacy of Iron Sucrose in Children". Comparison of three potential iron sucrose maintenance regimens in pediatric chronic kidney disease (CKD) patients

What is the current status of trial NCT00239642?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 141 participants. The study started on 2005-07. Estimated completion is 2010-04.

What interventions are being tested in trial NCT00239642?

The interventions under investigation include: Venofer (iron sucrose injection) (DRUG).

Who is sponsoring clinical trial NCT00239642?

This trial is sponsored by American Regent, which has 34 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.